A detailed history of Columbus Macro, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Columbus Macro, LLC holds 13,357 shares of ABBV stock, worth $2.34 Million. This represents 0.96% of its overall portfolio holdings.

Number of Shares
13,357
Previous 13,838 3.48%
Holding current value
$2.34 Million
Previous $2.37 Million 11.13%
% of portfolio
0.96%
Previous 0.94%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$163.84 - $199.33 $78,807 - $95,877
-481 Reduced 3.48%
13,357 $2.64 Million
Q2 2024

Jul 12, 2024

SELL
$154.79 - $180.76 $55,260 - $64,531
-357 Reduced 2.51%
13,838 $2.37 Million
Q1 2024

Apr 12, 2024

SELL
$159.82 - $182.1 $169,409 - $193,026
-1,060 Reduced 6.95%
14,195 $2.58 Million
Q4 2023

Jan 19, 2024

SELL
$137.6 - $154.97 $14,310 - $16,116
-104 Reduced 0.68%
15,255 $2.36 Million
Q3 2023

Oct 13, 2023

SELL
$133.59 - $154.65 $72,405 - $83,820
-542 Reduced 3.41%
15,359 $2.29 Million
Q2 2023

Jul 21, 2023

BUY
$132.51 - $164.9 $110,910 - $138,021
837 Added 5.56%
15,901 $2.14 Million
Q1 2023

Apr 27, 2023

BUY
$144.61 - $166.54 $13,159 - $15,155
91 Added 0.61%
15,064 $2.4 Million
Q4 2022

Feb 02, 2023

SELL
$138.31 - $165.87 $21,161 - $25,378
-153 Reduced 1.01%
14,973 $2.42 Million
Q3 2022

Oct 21, 2022

SELL
$134.21 - $153.93 $45,362 - $52,028
-338 Reduced 2.19%
15,126 $2.03 Million
Q2 2022

Jul 27, 2022

BUY
$137.62 - $174.96 $391,391 - $497,586
2,844 Added 22.54%
15,464 $2.37 Million
Q1 2022

Apr 26, 2022

BUY
$131.98 - $163.75 $65,726 - $81,547
498 Added 4.11%
12,620 $2.05 Million
Q4 2021

Jan 21, 2022

BUY
$107.43 - $135.93 $1.05 Million - $1.33 Million
9,811 Added 424.53%
12,122 $1.64 Million
Q3 2021

Oct 22, 2021

SELL
$106.4 - $120.78 $2,766 - $3,140
-26 Reduced 1.11%
2,311 $249,000
Q2 2021

Jul 21, 2021

SELL
$105.21 - $117.21 $3,156 - $3,516
-30 Reduced 1.27%
2,337 $263,000
Q1 2021

Apr 23, 2021

SELL
$102.3 - $112.62 $60,050 - $66,107
-587 Reduced 19.87%
2,367 $256,000
Q4 2020

Jan 26, 2021

SELL
$80.49 - $108.67 $30,827 - $41,620
-383 Reduced 11.48%
2,954 $317,000
Q3 2020

Oct 30, 2020

SELL
$85.91 - $100.83 $217,610 - $255,402
-2,533 Reduced 43.15%
3,337 $292,000
Q2 2020

Jul 31, 2020

SELL
$73.37 - $98.18 $166,329 - $222,574
-2,267 Reduced 27.86%
5,870 $576,000
Q1 2020

May 04, 2020

SELL
$64.5 - $97.79 $144,867 - $219,636
-2,246 Reduced 21.63%
8,137 $620,000
Q4 2019

Jan 27, 2020

BUY
$72.13 - $90.25 $230,166 - $287,987
3,191 Added 44.37%
10,383 $919,000
Q3 2019

Oct 22, 2019

SELL
$62.98 - $75.72 $94,784 - $113,958
-1,505 Reduced 17.3%
7,192 $545,000
Q2 2019

Jul 16, 2019

BUY
$65.7 - $83.98 $222,788 - $284,776
3,391 Added 63.91%
8,697 $632,000
Q1 2019

Apr 22, 2019

SELL
$77.14 - $90.79 $4,396 - $5,175
-57 Reduced 1.06%
5,306 $428,000
Q4 2018

Jan 14, 2019

SELL
$77.85 - $96.01 $15,492 - $19,105
-199 Reduced 3.58%
5,363 $494,000
Q3 2018

Oct 12, 2018

BUY
$88.91 - $98.84 $23,827 - $26,489
268 Added 5.06%
5,562 $526,000
Q2 2018

Jul 19, 2018

SELL
$89.78 - $106.23 $14,005 - $16,571
-156 Reduced 2.86%
5,294 $490,000
Q1 2018

Apr 17, 2018

SELL
$92.01 - $123.21 $97,898 - $131,095
-1,064 Reduced 16.33%
5,450 $516,000
Q4 2017

Feb 02, 2018

BUY
$89.56 - $98.21 $583,393 - $639,739
6,514
6,514 $630,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Columbus Macro, LLC Portfolio

Follow Columbus Macro, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Columbus Macro, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Columbus Macro, LLC with notifications on news.